Concert Bio
Concert Bio helps businesses manage their microbiome. We combine monitoring with analytics to develop interventions that improve the microbiome that matters to you.
Concert Bio has raised €1.7M across 1 funding round from 6 investors, most recently a Pre-Seed round in Aug 2022. Based in London, UK; active in Agritech. Data as of 28 Oct 2026.
London, UKwww.concert.bio ↗
Total raised
€1.7M
€1,661,292
Funding rounds
1
Investors
6
distinct backers
Active since
2022-08
latest 2022-08
Funding by year
EUR raised per yearConcert Bio — funding by year — interactive chart.
Data table
| Concert Bio — funding by year | |
|---|---|
| 2022 | €1.7M |
Signals
High confidenceRaise-next likelihood4
base rate 24% for Pre-Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-01 | Pre-Seed | €1.7M | Day One Capital,Nucleus Capital,Ponderosa Ventures,Potential VC,Tet Ventures,The Venture Collective | View deal → |
Investors
6Related news
- Concert Bio lands seed round to fix hydroponic farming’s ‘dirty secret’techcrunch.com · 2022-08
Similar companies
same sector or countryGlobal coverage: FundingData